Ligands with its PDB code and its tanimoto calculated from the molecule, present in the database, which has for MMscode: MMs03486277

Ligand	Ligand name	Chain	PDB	Tanimoto
COR	2,4-DIAMINO-1,5-DIPHENYL-3-HYDROXYPENTANE	A	9HVP	0.73
PR0	3(S)-AMINO-4-PHENYL-BUTAN-2(R)-OL	A,B,I	1ZSF	0.72
PR0	3(S)-AMINO-4-PHENYL-BUTAN-2(R)-OL	A	1JLD	0.72
PR0	3(S)-AMINO-4-PHENYL-BUTAN-2(R)-OL	A,B	1IDA	0.72
PR0	3(S)-AMINO-4-PHENYL-BUTAN-2(R)-OL	A,B	1IDB	0.72
PR0	3(S)-AMINO-4-PHENYL-BUTAN-2(R)-OL	A,B,I	1Z8C	0.72
PR0	3(S)-AMINO-4-PHENYL-BUTAN-2(R)-OL	A,B,I	1ZBG	0.72
PR0	3(S)-AMINO-4-PHENYL-BUTAN-2(R)-OL	A,B,I	1ZPK	0.72
BS2	(3-ENDO,8-ANTI)-8-BENZYL-3-(10,11-DIHYDRO-5H-DIBENZO[A,D][7]ANNULEN-5-YLOXY)-8-AZONIABICYCLO[3.2.1]OCTANE	A,D,E	2W8G	0.71
K7I	L-alanyl-N-[(1S,2R)-1-benzyl-2-hydroxypropyl]-L-alaninamide	A,B	2QXG	0.72
2SK	(1R,2R,3R,4S,5R)-4-(BENZYLAMINO)-5-(METHYLTHIO)CYCLOPENTANE-1,2,3-TRIOL	A	2F7P	0.75
PS0	3(S)-AMINO-4-PHENYL-BUTAN-2(S)-OL	A,B,I	1ZSR	0.72
PS0	3(S)-AMINO-4-PHENYL-BUTAN-2(S)-OL	I	1ZJ7	0.72
PS0	3(S)-AMINO-4-PHENYL-BUTAN-2(S)-OL	I	1ZLF	0.72
PS0	3(S)-AMINO-4-PHENYL-BUTAN-2(S)-OL	I	1HEG	0.72
PS0	3(S)-AMINO-4-PHENYL-BUTAN-2(S)-OL	I	1FQX	0.72
PS0	3(S)-AMINO-4-PHENYL-BUTAN-2(S)-OL	A,B,I	1IIQ	0.72
PS0	3(S)-AMINO-4-PHENYL-BUTAN-2(S)-OL	I	1HEF	0.72
GB3	(2R,3R,4S,5R)-2-({[(1R)-2-HYDROXY-1-PHENYLETHYL]AMINO}METHYL)-5-METHYLPYRROLIDINE-3,4-DIOL	A	2F1B	0.8
PIR	2-(4-AMINO-PHENYL)-5-HYDROXYMETHYL-PYRROLIDINE-3,4-DIOL	A,B,C,D	2MAS	0.73
GB7	(3R,4R,5R)-3,4-dihydroxy-5-({[(1R)-2-hydroxy-1-phenylethyl]amino}methyl)-1-methylpyrrolidin-2-one	A	3DDG	0.7
VAC	N,N-BIS(2-HYDROXY-1-INDANYL)-2,6- DIPHENYLMETHYL-4-HYDROXY-1,7-HEPTANDIAMIDE	B	4PHV	0.73
BAV	(3S,14R,16S)-16-[(1R)-1-hydroxy-2-{[3-(1-methylethyl)benzyl]amino}ethyl]-3,4,14-trimethyl-1,4-diazacyclohexadecane-2,5-dione	A,B,C	3DV5	0.74
216	[4-R-(4-ALPHA,6-BETA,7-BETA]-HEXAHYDRO-5,6-DI(HYDROXY)-1,3-DI(ALLYL)-4,7-BISPHENYLMETHYL)-2H-1,3-DIAZEPINONE	B	1HWR	0.72
TA2	(2R,3S)-3-AMINO-3-PHENYLPROPANE-1,2-DIOL	A,B	2IFR	0.75
VBZ	(1R,4R,5R,7R,8R)-2-Benzyl-5-hydroxymethyl-2-aza-bicyclo[2.2.2]octane-4,7,8-triol	A,B	2VO5	0.73
BLL	(2R,3R,4R,5R)-3,4-DIHYDROXY-N,N'-BIS[(1S,2R)-2-HYDROXY-2,3-DIHYDRO-1H-INDEN-1-YL]-2,5-BIS(2-PHENYLETHYL)HEXANEDIAMIDE	B	1WBM	0.74
SK3	(1R,2R,3S,4S,5R)-5-(BENZYLAMINO)CYCLOPENTANE-1,2,3,4-TETROL	A	2F7R	0.78
GB6	(3R,4R,5R)-3,4-dihydroxy-5-({[(1R)-2-hydroxy-1-phenylethyl]amino}methyl)pyrrolidin-2-one	A	3DDF	0.7
GB1	(2R,3R,4S)-2-({[(1R)-2-HYDROXY-1-PHENYLETHYL]AMINO}METHYL)PYRROLIDINE-3,4-DIOL	A	2F18	0.79
S13	(3S,5R,7R,8S,9S,10R)-7-(hydroxymethyl)-3-(4-methylphenyl)-1,6-dioxa-2-azaspiro[4.5]decane-8,9,10-triol	A	2QRQ	0.72
GB2	(2R,3R,4S)-2-({[(1S)-2-HYDROXY-1-PHENYLETHYL]AMINO}METHYL)PYRROLIDINE-3,4-DIOL	A	2F1A	0.79